Status:
COMPLETED
Identifying Factors Underlying the Discontinuation of Triptans
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Migraine
Medication Adherence
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study is to identify reasons migraine patients stop using triptan medications for abortive headache treatment. It is hypothesized that inadequate education of the patient at the ...
Eligibility Criteria
Inclusion
- Triptan User Inclusion Criteria:
- Episodic Migraine or Chronic Migraine
- Have used a triptan medication in the prior 3 months
- Have used triptan medications for at least 1 year
- Triptan Discontinuation Inclusion Criteria:
- Episodic Migraine or Chronic Migraine
- Used any triptan medication in the last 2 years
- Have not used a triptan medication in the last 6 months
Exclusion
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
292 Patients enrolled
Trial Details
Trial ID
NCT00890357
Start Date
August 1 2009
End Date
June 1 2012
Last Update
March 29 2013
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of South Florida College of Medicine
Tampa, Florida, United States, 33612
2
Washington University School of Medicine
St Louis, Missouri, United States, 63110
3
Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195